# Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

Study · id `cardio:ct-nct01056328` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01056328](<https://clinicaltrials.gov/study/NCT01056328>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01056328

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.

## Technical summary

Registry record NCT01056328. Randomized; single masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2014-05-23.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 324 participants (enrolled count; ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Primary completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Results first posted: 2014-05-23 (ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Countries: United States; Canada; South Korea (ClinicalTrials.gov record NCT01056328, source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01056328-2019-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
- Acronym: IRASE-AF
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): SJM Irrigated Cardiac Ablation System
- Intervention (Device): FDA approved Open Irrigated RF Ablation System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 818d5cb6c88569d6f74eed52c9305ce0a4426f064069733cc89db534e8e40987
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
